Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Receivables - Net (2017 - 2025)

Selectis Health's Receivables - Net history spans 11 years, with the latest figure at $3.2 million for Q3 2025.

  • For Q3 2025, Receivables - Net rose 67.73% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, up 67.73%, while the annual FY2024 figure was $2.6 million, 25.12% up from the prior year.
  • Receivables - Net for Q3 2025 was $3.2 million at Selectis Health, up from $3.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $4.4 million in Q3 2021 and bottomed at -$469302.0 in Q2 2022.
  • The 5-year median for Receivables - Net is $2.9 million (2023), against an average of $2.6 million.
  • The largest annual shift saw Receivables - Net plummeted 114.51% in 2022 before it soared 648.79% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $3.5 million in 2021, then dropped by 17.17% to $2.9 million in 2022, then decreased by 28.0% to $2.1 million in 2023, then grew by 25.12% to $2.6 million in 2024, then increased by 22.06% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Receivables - Net are $3.2 million (Q3 2025), $3.0 million (Q2 2025), and $2.9 million (Q1 2025).